Exercise and medication for weight loss while preserving muscle
Part of Hormones & metabolism clinical trials.
This study tests whether a type 2 diabetes medication (tirzepatide) combined with a supervised resistance training (weight lifting) program helps prevent muscle loss while losing weight. You will either receive the medication or a placebo, and all participants will follow a diet and exercise plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your body mass index (BMI) is 30 or higher.
- You have tried to lose weight through diet at least once without success.
- You are willing to learn to inject the study drug yourself and follow the study plan for about 6 months.
- If you are a woman who could become pregnant, you must agree to use highly effective birth control or remain abstinent during the study and for 30 days after the last injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This study looks at whether adding a structured exercise program to the weight-loss medication tirzepatide can improve muscle health and physical function in people who are overweight or obese. Participants will exercise while taking their usual medication, and the researchers will measure muscle quality and strength.
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This study tests a medication called tirzepatide (a type of GLP-1 drug) to see how it affects muscle and bone health during weight loss. It is for people with obesity who are not menopausal and do not have diabetes or bone disease.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
Hear when a new Obesity (BMI>30) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.